Sign in to continue:

Monday, January 26th, 2026
IPO

OneRobotics (Shenzhen) Co., Ltd. Global Offering: IPO Details, Application Process & Key Dates for Hong Kong Listing 2025

OneRobotics (Shenzhen) Co., Ltd. | December 18, 2025 | IPO Analysis and Investment Outlook

OneRobotics (Shenzhen) Co., Ltd.

Prospectus Dated: December 18, 2025

OneRobotics (Shenzhen) Co., Ltd. Launches Landmark Hong Kong IPO: Key Details, Investor Insights, and Outlook

IPO Snapshot

OneRobotics (Shenzhen) Co., Ltd. (“臥安機器人(深圳)股份有限公司”) is set to debut on the Hong Kong Stock Exchange under the stock code 6600. The company is offering H Shares in a global offering with substantial retail and institutional tranches.

  • IPO Symbol: 6600
  • Offer Price Range: HK\$63.00 to HK\$81.00 per H Share
  • Maximum Offer Price: HK\$81.00 per H Share (plus brokerage, SFC transaction levy, Stock Exchange trading fee, AFRC transaction levy)
  • Total Offer Size: 22,222,300 H Shares (subject to over-allotment)
  • Hong Kong Public Offering: 2,222,300 H Shares (subject to reallocation)
  • International Offering: 20,000,000 H Shares (subject to reallocation and over-allotment)
  • Nominal Value: RMB0.1 per H Share
  • Board Lot Size: 100 H Shares
  • Stock Code: 6600
  • Listing Date: Expected December 30, 2025

Allotment and pricing mechanisms are designed to support robust investor demand with a fully electronic application process.

Offering Segment Number of Shares Subject to Reallocation/Over-allotment
Hong Kong Public Offering 2,222,300 Yes
International Offering 20,000,000 Yes
Total Global Offering 22,222,300 Yes

Over-allotment option (“greenshoe”) available for up to 1,111,000 H Shares.

Application window: December 18, 2025 (9:00 a.m.) to December 23, 2025 (12:00 noon)

Expected trading commencement: December 30, 2025 (9:00 a.m.)

Electronic application only via White Form eIPO or HKSCC EIPO channel.

Placement and Issuance Breakdown

  • Hong Kong Public Offering: 2,222,300 H Shares, open only to Hong Kong residents.
  • International Offering: 20,000,000 H Shares, available to institutional investors outside the United States.
  • Maximum reallocation mechanism: Up to 1,111,000 Offer Shares may be transferred from International to Hong Kong Public Offering under specific oversubscription scenarios, raising the Hong Kong retail tranche to 15% of the total offer.

No physical application channels; all applications are electronic.

All application payments must be made in full upon submission.

Investor Participation and Book Quality

  • Joint Sponsors and Overall Coordinators: Guotai Junan Securities (Hong Kong) Limited (Stabilizing Manager), plus other joint bookrunners and joint lead managers.
  • Stabilization Mechanism: Over-allotment option (“greenshoe”) and price stabilization permitted for up to 30 days post-listing.
  • Strong institutional support inferred by the size of the International Offering and structure of price stabilization.

Book quality is robust with mechanisms to reallocate shares based on demand, supporting potential for strong first-day performance.

Deal Parties and Structure

  • Joint Sponsors, Overall Coordinators, Joint Global Coordinators, Joint Bookrunners, and Joint Lead Managers: Guotai Junan Securities (Hong Kong) Limited and others (alphabetical order, full list available on company website).
  • Underwriters: Named in prospectus with defined termination rights prior to listing.
  • Stabilizing Manager: Guotai Junan Securities (Hong Kong) Limited

Listing day performance is expected to be supported by stabilization activities and a strong syndicate of investment banks.

Company Overview and Business Model

OneRobotics (Shenzhen) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China with limited liability. The business is focused on robotics and automation, with revenues generated from the sale of robotics products and related services. The company’s key offerings target industrial, commercial, and technology customers, with an emphasis on innovation and automation solutions.

  • Revenue Streams: Sale of robotics products (H Shares), automation solutions, and services.
  • Customer Segments: Industrial manufacturers, commercial enterprises, technology firms.
  • Geographic Markets: Primarily China, with expansion into international markets through the global offering.

Management Team:

  • Executive Director & CEO: Mr. Li Zhichen
  • Executive Directors: Mr. Pan Yang, Mr. Hu Zhidong, Ms. Yang Minghui
  • Non-executive Directors: Prof. Li Zexiang, Prof. Ko Ping Keung
  • Independent Non-executive Directors: Ms. Li Hui, Dr. Leung Suk Wai Winnie, Prof. Wang Yong

Market Position and Competitive Advantages

OneRobotics positions itself as a leading provider of robotics automation in China, aiming to leverage technology innovation and a strong management team to capture market share in both domestic and international markets.

  • Competitive Advantages: Advanced technology, experienced leadership, focused product portfolio.
  • Brand Strength: Recognized for quality and innovation within its sector.

Sector Trends, Timing, and Market Environment

Robotics and automation are experiencing robust demand in China and globally, driven by industrial upgrading, labor cost pressures, and technological advances.

  • IPO Application Period: December 18, 2025 (9:00 a.m.) to December 23, 2025 (12:00 noon)
  • Listing Date: December 30, 2025
  • Dealings in H Shares on the Stock Exchange expected to commence at 9:00 a.m. on December 30, 2025

Recent developments: The company is expanding internationally and converting unlisted shares to H Shares for wider investor access.

Market conditions inferred as favorable, supported by strong syndicate, stabilization mechanism, and sector demand.

Risk Factors

Key risks disclosed include:

  • Legal and Regulatory: Subject to Hong Kong Securities and Futures Ordinance, international securities laws.
  • Market Risk: Demand for H Shares and price could fall after the stabilization period.
  • Jurisdictional Risk: Offer not available to US persons or other prohibited jurisdictions.
  • Application Risk: No physical channels for application may limit retail participation.
  • Settlement/Trading Risk: Investors trading before receiving valid share certificates do so at their own risk.

Growth Strategy

Expansion plans focus on:

  • International market entry through the global offering
  • Conversion of unlisted shares to H Shares for increased liquidity and capital access
  • Technology advancement and product development driven by proceeds from the IPO

Ownership and Lock-ups

  • Shareholding Structure: H Shares issued and converted from unlisted shares post-IPO.
  • Major Shareholders: Details available on the company website.
  • ESOPs/Employee Allocation: Not specifically disclosed.

Listing Outlook

Based on disclosed facts, the IPO appears well structured for a strong first-day performance:

  • Substantial offer size and investor demand mechanisms suggest robust participation.
  • Price stabilization and over-allotment options will support market price post-listing.
  • Sector momentum and timing align with favorable market trends.

Estimated first-day trading range: Likely to open near the offer price, with potential for upward movement if oversubscription occurs and stabilization is employed.

Prospectus Access

Prospectus and further details can be accessed at:

  • www.onero.cn
  • www.hkexnews.hk

How to Apply

Application Channels:

  • White Form eIPO service (www.eipo.com.hk) for investors seeking physical share certificates
  • HKSCC EIPO channel via brokers/custodians for investors preferring electronic settlement in CCASS

Application Timeline: December 18, 2025 (9:00 a.m.) to December 23, 2025 (12:00 noon)

Application Steps: Apply online through designated platforms, pay full application amount, minimum application 100 H Shares.

Tungsten is running hot — can Jiaxin spark a new HK metals trade?

📌 Company Overview Name: Jiaxin International Resources Investment Limited (佳鑫國際資源投資有限公司) Business: Tungsten mining company, focused on the Boguty tungsten mine in Kazakhstan. Project: World’s largest open-pit tungsten mine (by WO₃ mineral resources as of...

Innovative Biopharmaceutical Company Launches First Long-Acting Recombinant FSH-CTP (SJ02) in China, Advances Synthetic Biology Drug Pipeline and Global Expansion 10344351375

Shanghai Bao Pharmaceuticals Co., Ltd. – 2025 Hong Kong IPO Analysis, Growth Prospects, and Investor Outlook Shanghai Bao Pharmaceuticals Co., Ltd. Date of Prospectus: December 2, 2025 Shanghai Bao Pharmaceuticals’ Landmark Hong Kong IPO:...

Forest Cabin: Leading Chinese Premium Skincare Brand with Innovative Camellia-Based Anti-Wrinkle Solutions and OMO Retail Strategy 171174177180182120

Forest Cabin IPO Analysis: Offer Price, Deal Structure, Financials, Growth & Risks Company: Forest Cabin Date of Prospectus: December 17, 2025 Forest Cabin’s HK IPO: Deep Dive on Financials, Growth, Key Investors, and Listing...